Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
Por um escritor misterioso
Descrição
Frontiers Silver Jubilee of Stroke Thrombolysis With Alteplase: Evolution of the Therapeutic Window
Intravenous recombinant tissue plasminogen activator (IV rt-PA)
Factors Driving Expanded Use of Tissue Plasminogen Activator for Acute Ischemic Stroke - ACEP Now
Tissue-type plasminogen activator - Wikipedia
Ischaemic stroke Stroke Association
Safety of Mechanical Thrombectomy and Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke. Results of the Multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) Trial, Part I
Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke
Approach to reperfusion therapy for acute ischemic stroke - UpToDate
Trends in acute ischemic stroke treatments and mortality in the United States from 2012 to 2018 in: Neurosurgical Focus Volume 51 Issue 1 (2021) Journals
Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial - The Lancet Neurology
:max_bytes(150000):strip_icc()/GettyImages-184312650-58f63f583df78ca159f37a44.jpg)
tPA (Tissue Plasminogen Activator) for Stroke
Thrombus composition and thrombolysis resistance in stroke - Research and Practice in Thrombosis and Haemostasis
Pharmacological brain cytoprotection in acute ischaemic stroke — renewed hope in the reperfusion era
Full article: Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke
Prothymosin alpha and its mimetic hexapeptide improve delayed tissue plasminogen activator‐induced brain damage following cerebral ischemia - Halder - 2020 - Journal of Neurochemistry - Wiley Online Library
de
por adulto (o preço varia de acordo com o tamanho do grupo)
